Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-07-28 Sale |
2023-07-31 4:48 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
2,683 | $11.8 | $31,659 | 237,904 (Direct) |
View |
2023-07-28 Sale |
2023-07-31 4:46 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
1,628 | $11.8 | $19,210 | 131,887 (Direct) |
View |
2023-06-27 Sale |
2023-06-28 5:12 pm |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
244 | $12.12 | $2,957 | 318,160 (Direct) |
View |
2023-06-27 Sale |
2023-06-28 5:08 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
294 | $12.12 | $3,563 | 147,829 (Direct) |
View |
2023-06-27 Sale |
2023-06-28 5:06 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
647 | $12.12 | $7,842 | 240,587 (Direct) |
View |
2023-06-27 Sale |
2023-06-28 5:02 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
294 | $12.12 | $3,563 | 133,515 (Direct) |
View |
2023-04-28 Sale(A) |
2023-06-01 6:21 pm |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
1,657 | $11.16 | $18,492 | 156,586 (Direct) |
View |
2023-04-28 Sale(A) |
2023-06-01 6:19 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
2,012 | $11.16 | $22,454 | 148,123 (Direct) |
View |
2023-04-28 Sale(A) |
2023-06-01 6:17 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
2,850 | $11.16 | $31,806 | 241,234 (Direct) |
View |
2023-04-28 Sale(A) |
2023-06-01 6:14 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
1,936 | $11.16 | $21,606 | 133,809 (Direct) |
View |
2023-04-28 Sale |
2023-05-01 4:33 pm |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
739 | $11.16 | $8,247 | 157,504 (Direct) |
View |
2023-04-28 Sale |
2023-05-01 4:31 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
863 | $11.16 | $9,631 | 149,272 (Direct) |
View |
2023-04-28 Sale |
2023-05-01 4:29 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
1,383 | $11.16 | $15,434 | 242,701 (Direct) |
View |
2023-04-28 Sale |
2023-05-01 4:26 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
863 | $11.16 | $9,631 | 134,882 (Direct) |
View |
2023-03-27 Sale |
2023-03-28 4:52 pm |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
297 | $15.36 | $4,562 | 158,243 (Direct) |
View |
2023-03-27 Sale |
2023-03-28 4:50 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
347 | $15.36 | $5,330 | 150,135 (Direct) |
View |
2023-03-27 Sale |
2023-03-28 4:49 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
763 | $15.36 | $11,720 | 244,084 (Direct) |
View |
2023-03-27 Sale |
2023-03-28 4:47 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
347 | $15.36 | $5,330 | 135,745 (Direct) |
View |
2023-02-07 Sale |
2023-02-09 5:09 pm |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
42,000 | $20.99 | $881,720 | 3,110,240 (Indirect Direct) |
View |
2023-01-30 Sale |
2023-01-31 4:29 pm |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
740 | $21.56 | $15,954 | 158,540 (Direct) |
View |
2023-01-30 Sale |
2023-01-31 4:23 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
864 | $21.56 | $18,628 | 150,482 (Direct) |
View |
2023-01-30 Sale |
2023-01-31 4:20 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
1,429 | $21.56 | $30,809 | 244,847 (Direct) |
View |
2023-01-30 Sale |
2023-01-31 4:15 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
864 | $21.56 | $18,628 | 136,092 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 8:33 pm |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
84,000 | $20.37 | $1,711,360 | 4,681,600 (Indirect Direct) |
View |
2023-01-12 Sale |
2023-01-13 4:05 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
9,994 | $20 | $199,880 | 51,531 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-31 Option Award |
2023-06-01 6:44 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | HILL LINDA A Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:42 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | INGRAM DOUGLAS S Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:39 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:37 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Murcko Mark Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:36 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Rubin Jami Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:31 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-31 Option Award |
2023-06-01 6:27 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
66,055 | $0 | 66,055 (Direct) |
View |
2023-05-30 Option Award |
2023-06-01 6:24 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
161,818 | $0 | 318,404 (Direct) |
View |
2023-05-24 Gift |
2023-05-26 4:14 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
12,099 | $0 | 40,000 (Direct) |
View |
2023-02-07 Exercise |
2023-02-09 5:09 pm |
N/A 2029-04-22 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
42,000 | $0 | 3,110,240 (Direct) |
View |
2023-02-07 Exercise |
2023-02-09 5:09 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
42,000 | $5.04 | 3,110,240 (Direct) |
View |
2022-10-28 Ownership |
2023-01-31 4:27 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
254,554 | $0 | 1,361,903 (Direct) |
View |
Ownership |
2023-01-31 4:27 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
0 | $0 | 1,361,903 (Indirect) |
View |
2023-01-17 Option Award |
2023-01-19 8:36 pm |
N/A 2033-01-16 |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
195,260 | $0 | 354,540 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:33 pm |
N/A 2029-04-22 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
84,000 | $0 | 4,681,600 (Direct) |
View |
2023-01-17 Option Award |
2023-01-19 8:33 pm |
N/A 2033-01-16 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
1,403,360 | $0 | 4,681,600 (Direct) |
View |
2023-01-17 Exercise |
2023-01-19 8:33 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
84,000 | $5.04 | 4,681,600 (Direct) |
View |
2023-01-17 Option Award |
2023-01-19 8:31 pm |
N/A 2033-01-16 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Chief Financial Officer |
303,345 | $0 | 353,576 (Direct) |
View |
2023-01-17 Option Award |
2023-01-19 8:29 pm |
N/A 2033-01-16 |
Relay Therapeutics Inc. | RLAY | Adams Brian Chief Legal Officer |
256,275 | $0 | 307,806 (Direct) |
View |
2023-01-17 Option Award |
2023-01-19 8:28 pm |
N/A 2033-01-16 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A President, R&D |
320,780 | $0 | 567,056 (Direct) |
View |
Ownership |
2023-01-05 6:32 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Rahmer Peter See remarks |
0 | $0 | 304,940 (Direct) |
View |